Logo
Secure Registration

International Conference on Drug Action in Pharmacy

ICDAPY

20th Feb – 21st Feb 2027 Birmingham, UK

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

1

Select Registration Mode

2

Participant Details

3

Coupon Code

4

Terms & Condition

Read the full Terms & Conditions

Conference Session Tracks

UN SDG Wheel

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

SDG 3 SDG 4 SDG 9
01 Advancements in Pharmacology +
This track focuses on the latest research in pharmacology, emphasizing drug action mechanisms and their implications for therapeutic efficacy. Participants will explore novel pharmacological agents and their potential applications in clinical settings.
SDG 3 SDG 4
02 Clinical Pharmacology and Patient Care +
This session addresses the integration of clinical pharmacology into direct patient care practices. Discussions will highlight personalized medicine approaches and the optimization of drug therapy for diverse patient populations.
SDG 3 SDG 4
03 Drug Design and Synthesis +
This track delves into the methodologies of drug design and synthesis, exploring innovative techniques in the creation of pharmaceutical compounds. Researchers will present findings on the chemical structures and properties that influence drug efficacy.
SDG 9
04 Neuropharmacology and Psychopharmacology +
Focusing on the effects of drugs on the nervous system, this session will cover neuropharmacological mechanisms and their relevance to mental health treatments. The interplay between pharmacological agents and psychological outcomes will be critically examined.
SDG 3 SDG 4
05 Pharmacodynamics and Pharmacokinetics +
This track investigates the principles of pharmacodynamics and pharmacokinetics, emphasizing their roles in drug action and therapeutic outcomes. Presentations will cover absorption, distribution, metabolism, and excretion of drugs.
SDG 3
06 Toxicology and Drug Safety +
This session addresses the critical aspects of toxicology in relation to drug safety and efficacy. Experts will discuss the assessment of drug toxicity and its implications for public health.
SDG 3 SDG 4
07 Chemical Biology in Drug Action +
This track explores the intersection of chemical biology and pharmacology, focusing on the biochemical mechanisms underlying drug action. Participants will discuss the role of bioactive compounds in modulating biological processes.
SDG 3 SDG 4
08 Emergency Medicine and Pharmacotherapy +
This session highlights the role of pharmacotherapy in emergency medicine, emphasizing rapid interventions and drug management in acute care settings. Case studies will illustrate the application of pharmacological principles in life-threatening situations.
SDG 3 SDG 4
09 Drug Classes and Therapeutic Applications +
This track categorizes various drug classes and their therapeutic applications, examining the specificities and affinities of different pharmacological agents. Discussions will include the clinical implications of drug classifications.
SDG 3
10 Molecular Mechanisms of Drug Action +
Focusing on the molecular and cellular mechanisms of drug action, this session will explore signal transduction pathways and their relevance to pharmacological interventions. Researchers will present insights into how drugs interact at the cellular level.
SDG 3 SDG 4
11 Emerging Trends in Pharmacy Practice +
This track addresses the evolving landscape of pharmacy practice, including advancements in pharmaceutical care and the role of pharmacists in healthcare teams. Discussions will focus on innovative practices that enhance patient outcomes.
SDG 3 SDG 4